Inside Mount Sinai Print Edition

In this issue –  January 27, 2020 –  February 9, 2020 

• The genetic variation TTR V142I, which is prevalent in people of African or Hispanic/Latino ancestry, was strongly associated with heart failure in a study led by Girish Nadkarni, MD.

• Joshua Brody, MD, and a team of researchers are pioneering two novel approaches to cancer immunotherapy for patients with non-Hodgkin Lymphoma and other solid tumors. Their work appears in separate studies in Nature Medicine and Cancer Discovery.

• Gregory Levitin, MD, a top specialist in hemangiomas at New York Eye and Ear Infirmary, performed life-changing surgery on one year-old Noor, whose family flew here from Kuwait.

• The Mount Sinai Medical-Legal Partnership celebrated two new pediatric initiatives and honored the late Mount Sinai Trustee Blaine V. “Fin” Fogg.

• Artists who work with Mount Sinai Health System patients through University Settlement’s Hospital Artist-In-Residence Program, were honored at an appreciation luncheon.

• The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai received the first place award for most accepted abstracts by residents at the 2019 Congress of Neurological Surgeons Annual Meeting.

• The Jack and Lucy Clark Department of Pediatrics held its largest fundraiser of the year with a private performance of the Big Apple Circus. Patients with Parkinson’s disease were honored for their participation in clinical trials at a luncheon hosted by physicians at Mount Sinai Beth Israel and members of The Michael J. Fox Foundation.

Past Issues